A detailed history of Vigilant Capital Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 3,345 shares of CTLT stock, worth $212,340. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,345
Previous 4,124 18.89%
Holding current value
$212,340
Previous $271,000 46.49%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$31.86 - $67.26 $24,818 - $52,395
-779 Reduced 18.89%
3,345 $145,000
Q1 2023

May 01, 2023

SELL
$45.44 - $74.26 $5.43 Million - $8.87 Million
-119,467 Reduced 96.66%
4,124 $271,000
Q4 2022

Jan 26, 2023

SELL
$41.39 - $81.0 $497,466 - $973,539
-12,019 Reduced 8.86%
123,591 $5.56 Million
Q3 2022

Oct 25, 2022

BUY
$72.36 - $113.1 $169,105 - $264,314
2,337 Added 1.75%
135,610 $9.81 Million
Q2 2022

Jul 06, 2022

BUY
$87.2 - $114.05 $47,611 - $62,271
546 Added 0.41%
133,273 $14.3 Million
Q1 2022

Apr 07, 2022

BUY
$94.19 - $124.49 $268,535 - $354,920
2,851 Added 2.2%
132,727 $14.7 Million
Q4 2021

Jan 06, 2022

BUY
$119.57 - $139.07 $438,821 - $510,386
3,670 Added 2.91%
129,876 $16.6 Million
Q3 2021

Oct 08, 2021

SELL
$109.17 - $142.35 $263,208 - $343,205
-2,411 Reduced 1.87%
126,206 $16.8 Million
Q2 2021

Jul 09, 2021

SELL
$100.34 - $115.69 $403,467 - $465,189
-4,021 Reduced 3.03%
128,617 $13.9 Million
Q1 2021

Apr 16, 2021

SELL
$101.51 - $125.27 $614,237 - $758,008
-6,051 Reduced 4.36%
132,638 $14 Million
Q4 2020

Jan 14, 2021

BUY
$85.88 - $105.36 $10,992 - $13,486
128 Added 0.09%
138,689 $14.4 Million
Q3 2020

Oct 15, 2020

SELL
$72.74 - $92.5 $377,447 - $479,982
-5,189 Reduced 3.61%
138,561 $11.9 Million
Q2 2020

Jul 10, 2020

SELL
$48.02 - $79.04 $722,460 - $1.19 Million
-15,045 Reduced 9.47%
143,750 $10.5 Million
Q1 2020

Apr 17, 2020

BUY
$36.95 - $62.95 $5.87 Million - $10 Million
158,795 New
158,795 $8.25 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Vigilant Capital Management, LLC Portfolio

Follow Vigilant Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.